Your browser does not support JavaScript!

b
Logo

UK

University of Aberdeen
Institute of Medical Sciences
Aberdeen
AB25 2ZD

e: info@mycobiologics.com

targeted treatment of serious infections

Harnessing immunotherapy to revolutionise antifungal treatment

At mycoBiologics, we are pioneering a new era in the fight against life-threatening fungal infections.

Our innovative approach leverages patient-derived human monoclonal antibodies (mAbs) to create a novel class of antifungal therapies.

Designed to combat critical Candida infections in hospitalized patients, our treatment offers a paradigm shift from traditional antifungals—harnessing the body’s natural immune defences to precisely target and eliminate infections.